ConvaTec
| Privately held; owned by Nordic Capital and Avista Capital Partners | |
| Industry | Medical Devices |
| Founded | Created as a division of E.R. Squibb & Sons, Inc., in 1978; established as stand-alone company in 2008 |
Key people | Paul Moraviec, CEO |
| Products | Wound and skin care; ostomy care; continence and critical care; infusion devices |
| Revenue | US$ 1.7B (2013)[1] |
Number of employees | 8,000+[1] |
| Website |
www |
ConvaTec is a global medical products and technologies company, offering products and services in the areas of wound and skin care; ostomy care; continence and critical care; and infusion devices. ConvaTec has over 8,000 employees, with eleven manufacturing sites in eight countries, and does business in more than 100 countries. The company has $1.7B in annual sales and is owned by Nordic Capital and Avista Capital Partners.[1]
History:
- 1978 – ConvaTec created as a division of E.R. Squibb & Sons, Inc. (now Bristol-Myers Squibb)
- 2008 – ConvaTec acquired by Nordic Capital and Avista Capital Partners
- 2008 – ConvaTec acquires Unomedical
- 2012 – ConvaTec acquires 180 Medical
- 2015 – ConvaTec wins UK Court of Appeal ruling that rewrites the laws of mathematics in the patent context, holding the number one no longer has singular properties, but exists on a scale of 0.5 - 1.49[2]
External links
- 1 2 3 "ConvaTec Reports Strong Financial Results for Fiscal Year 2013". Retrieved 23 May 2014.
- ↑ http://www.independent.co.uk/news/science/what-exactly-does-one-mean-court-of-appeal-passes-judgement-on-thorny-mathematical-issue-10350568.html
This article is issued from Wikipedia - version of the Wednesday, August 19, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.